InformationClinical trials have complex eligibility criteria.
Always talk to your clinician about you’re interest in participating in a trial.Learn why

Optimise reading forHealth ProfessionalsPatients

RecruitingLast updated:15 August 2023

PROTAC CLL: This Phase I trial is seeking to understand the recommended dose of a targeted therapy (BGB-16673) in people with B-Cell MalignanciesA Phase 1, Open-Label, Dose-Escalation and -Expansion Study of the Bruton Tyrosine Kinase-Targeted Protein-Degrader BGB-16673 in Patients With B-Cell Malignancies

Clinical summary

Summary

This is a non-randomised trial trial with two parts in people with B-Cell Malignancies including Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma, and Waldenström Macroglobulinemia. In Part 1 (Monotherapy Dose Finding) participants will receive BGB-16673 administered as a once daily regimen. In Part 2 (two Expansion cohorts) BGB-16673 will also be administered as a once daily regimen.

Age

People18+

Phase

I

Trial Acronym

PROTAC CLL

More information

Trial Identifiers

Use the hyperlinks, where available to access additional clinical trial information.

Commercial Sponsor

BeiGene Australia Pty Ltd

Scientific Title

A Phase 1, Open-Label, Dose-Escalation and -Expansion Study of the Bruton Tyrosine Kinase-Targeted Protein-Degrader BGB-16673 in Patients With B-Cell Malignancies

Eligibility

Inclusion

  • You have been diagnosed with a prior or secondary type of cancer.
Message

Clinical trials have complex eligibility criteria.

Ask your doctor if this trial could be right for you.

Participating hospitals

Recruiting hospitals

InformationTell us if you find this trial availability is not accurate.Report inaccuracy

Get Support

Example

Cancer Connect

Speak with someone who has cancer clinical trial experience.

Learn more

Example

Cancer Council’s cancer nurses

If you need cancer information and practical support for yourself, a carer, family or friend, contact Cancer Council’s experienced cancer nurses on 131120.

Learn more

Example

Information for family, friends and carers

When you are considering a cancer clinical trial, it is a good idea to discuss it with your family, friends or carers.

Learn more

CloseReport inaccuracy

Thank you for helping us to increase accuracy of the trial. Our team will validate the information and update the information as soon as possible.

Submitting ... Please wait